Detalhe da pesquisa
1.
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML.
Cancer Discov
; 12(2): 432-449, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531254
2.
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active.
Blood Adv
; 5(24): 5536-5545, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614506
3.
BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics.
Cell Death Differ
; 27(3): 999-1007, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332296
4.
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
Cancer Cell
; 38(6): 872-890.e6, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217342